Cellebrite stock holds at USD 11.62 as 2026 targets stay intact

Published on 09/23/2026 at 02:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cellebrite stock closed at USD 11.62 on September 18, 2026, while full-year ARR guidance stands at USD 550 million to USD 560 million. Adjusted EBITDA guidance is USD 153 million to USD 159 million.

CLBT, IL0011384071, Illustration mit AI erstellt.

Cellebrite DI Ltd. (IL0011384071) closed at USD 11.62 on Nasdaq on September 18, 2026, down 1.69 percent from the prior close of USD 11.82. The latest reported outlook keeps full-year 2026 annual recurring revenue at USD 550 million to USD 560 million and adjusted EBITDA at USD 153 million to USD 159 million.

Guidance sets the central benchmark

According to Seeking Alpha on September 22, 2026, Cellebrite forecasts full-year 2026 ARR of USD 550 million to USD 560 million and has lifted its adjusted EBITDA target to USD 153 million to USD 159 million amid slower deal timing. The guidance range gives investors two operating markers: recurring revenue growth remains the expansion measure, while the EBITDA range defines the profitability hurdle.

The latest available quarterly comparison is also positive on earnings. Yahoo Finance lists Q2 fiscal 2026 adjusted earnings per share at USD 0.11 against an estimate of USD 0.113, while Q1 fiscal 2026 revenue was USD 128.3 million and earnings were USD 10.94 million, with a profit margin of 8.53 percent.

Revenue scale meets a valuation test

Yahoo Finance reports trailing twelve-month revenue of USD 514.29 million and trailing twelve-month earnings per share of USD 0.23. Against the 2026 ARR target midpoint of USD 555 million, the recurring-revenue goal is USD 40.71 million above the trailing revenue figure, a comparison that highlights the importance of converting contracted growth into recognized revenue.

The stock remains below the reported 52-week high of USD 19.98 and above the 52-week low of USD 9.58. That range places the September 18 close of USD 11.62 USD 8.36 below the high and USD 2.04 above the low, so the valuation discussion is still tied to execution rather than a new high.

Stock stays near USD 12

Cellebrite stock closed at USD 11.62 on Nasdaq on September 18, 2026, with a reported market capitalization of about USD 2.91 billion and volume of 1,611,459 shares. The next estimated earnings date listed by Yahoo Finance is November 11, 2026.